Study Group: Users of Triage BNP Test (US)
Council Members in this Study Group: 35
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Contact Gerson Lehrman Group to survey or consult with members of this Study Group
Leading institutions connect with members of this Study Group through GLG
Leading Experts in this Study Group
John WaughDirector of System Laboratory Operations
HENRY FORD HEALTH SYSTEM
John Waugh is the Director of System Laboratory Operations at Henry Ford Health System, one of the top ten US laboratories in size. In this research and academic medical center in Detroit, Mr. Waugh has expertise in new and emerging clinical and molecular...
Stan SchofieldManaging Principal
The Compass Group, ScarboroughStan Schofield, MS, MHA, MT (ASCP), is President of NorDx, a regional laboratory corporation which is part of the Maine Health System. He also serves as a Vice President and senior member of the health system executive management team. Mr. Schofield is...
- John Cochran
Founder and Senior Pathologist
Chestatee Pathology Associates, PCJohn Cochran, MD, is the Founder and the Chief Executive Officer of Chestatee Pathology Associates in Atlanta, GA. He is also the Medical Director of two Atlanta-area hospital laboratories and founded the first independent podiatric pathology laboratory...
Rohit AroraProfessor of Medicine
Finch University of Health Science-Chicago Medical SchoolRohit Arora, MD, FACC, FAHA, FASCI, FACP, is Professor of Medicine and Professor of Physiology and Biophysics at Chicago Medical School. He is also the Chairman of Cardiology and Associate Chairman of Medicine in the Department of Medicine. Previously,...
- Joseph Schappert
Medical Director
PROVIDENCE HEALTH CAREJoseph Schappert, MD, is the Chief Medical Officer at Pathology Associates Medical Laboratories (PAML) and the Medical Director for Providence Health Care System. He was previously the Global Medical Director at ICON Central Laboratories, where he was...
GLG NewsSM Analyses by this Study Group's Leading Experts(?)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
-
February 13, 2009
Analysis by: Joseph Schappert, Medical Director ,Dako announces a collaboration with OSI Pharmaceuticals, Inc. on Companion Diagnostics | www.tmcnet.com
The ability of pharma and biotech to leverage the rapid expansion in our knowledge base on cell surface, nuclear and cytoplasmic signaling and messaging systems has and will continue to produce novel targeted molecules. To identify which patients will respond and potential surrogate markers for the assessment of a molecule's success will require reagents that are applied to histologic sections. These capabilities, combined with imaging and data reduction of the stained sections, should be anticipated to provide a very lucrative market for companies in this diagnostic arena and to facilitate the timely introduction of effective novel markers.
-
If it seems too good to be true...it probably is.
December 9, 2008
Analysis by: Joshua Feuer, Owner,Generic Heart Drugs as Good as Brand-Name Counterparts | www.washingtonpost.com
This article implies that physician's have no justifiable reason for prescribing brand-name drugs. Unfortunately, it's not that simple.
-
December 8, 2008
Analysis by: Joshua Feuer, Owner,There is a question of bias in this study. It is not prospective, not randomized and not blinded and thus no valid conclusions can be made. The study should be ignored. It will have no impact on sales.
-
Novel molecules and diagnostic tests
February 19, 2008
Analysis by: Joseph Schappert, Medical Director ,Kidney Cancer Drug Linked to Higher Rate of Heart Problems | www.washingtonpost.com
Diagnostic tools are availible to identify these adverse effects at an early stage in their clinical development. These tools should mitigate the seriousness of these adverse events.
-
Microrganisms elude our control
March 5, 2007
Analysis by: Joseph Schappert, Medical Director ,Proof Nailed Down that Antibiotics Use Leads to Resistance | www.medpagetoday.com
Our experience with antibiotics has consistently shown that resistance occurs within 3-5 years of their widespread utilization. Our more recent experience with antiviral agents has been similar. Without diminishing the important role that antimicrobials have played in our recent history, it has also underscored their limitations. While this is of concern, there is also considerable concern in the international microbiology community regarding mutations within microorganisms that would allow them to 'jump species' and infect humans, or would enhance the virulence of existing pathogens. This fear is enhanced by the indiscriminate utilization of antimicrobial agents associated with ‘modern’ agricultural practices worldwide, which are changing the microbial ecology and potentially selecting out new pathogens to humans and/or to our food supply.
Members in this Study Group include these company types:
- Academic Medical Center/Hospital or Clinic
- Lab, Academic Medical Center
- Lab, Non-Academic/Community Hospital
- Non-Academic Community Hospital or Clinic
- Academic Institution*
- Laboratory, Independent
- Office Based Private Practice or Clinic
- Government/Military Hospital or Clinic
- Integrated Healthcare Delivery Network (IDN)
Members in this Study Group often have these job titles:
- Physician - Attending Physician
- Director
- Research Scientist
- Physician - Director
- Manager
- Physician - Department Chair
Related Study Groups
GLG Live Meetings with this Study Group's Leading Experts (?)
June 26, 2008 | Palo Alto
GLG Seminar: Molecular Platforms and Laboratory TechnologyGLG Webcasts & Teleconferences
Leading Experts in Users of Triage BNP Test (US) have not participated in any GLG webcasts.